Bristol-Myers Squibb Reports Second Quarter Financial Results

Go back to Bristol-Myers Squibb Reports Second Quarter Financial Results

Bristol-Myers Squibb (BMY) Tops Q2 EPS by 17c; Boosts FY15 EPS Outlook

July 23, 2015 7:31 AM EDT

Bristol-Myers Squibb (NYSE: BMY) reported Q2 EPS of $0.53, $0.17 better than the analyst estimate of $0.36. Revenue for the quarter came in at $4.16 billion versus the consensus estimate of $3.71 billion.

SECOND QUARTER BUSINESS DEVELOPMENT UPDATE

In... More